GLP1ra’s beyond obesity and diabetes: Is the sky the limit?

Glucagon-like peptide-1 receptor agonists (GLP1Ra’s) have taken the type 2 diabetes and obesity market by storm. Outside of the pharmaceutical industry, Wegovy and Zepbound are becoming household names with the products becoming popular with influencers on social media.